COMPANY

Mucommune

HQ: Morrisville, NC source · mucommune.com ↗ · Southeast

Location: Morrisville, NC · source · Oct 15, 2026

Profile checked Oct 10, 2026

35NIH grants

Funding and NIH signals

NIH award NIH awarded $1.16M (SBIR Phase II 1R44HD121291-01, new, notice Sep 17, 2026); 14 NIH awards totaling $11.08M in the last 12 months. NIH RePORTER 1R44HD121291-01 (Sep 17, 2026)
Evidence (14 events)
- Sep 17, 2026 · NIH RePORTER 1R44HD121291-01
  Organization: MUCOMMUNE, LLC; City/State: Morrisville, NC; Project number: 1R44HD121291-01; Activity code: R44; Fiscal year: 2026; Award notice date: 2026-09-17; FY total cost (award amount): 1163587; Administering IC: Eunice Kennedy Shriver National Institute of Child Health and Human Development; Project title: IND-enabling development of MM012, an antibody-based non-hormonal contraceptive intravaginal ring; Organization type: Domestic For-Profits
- Sep 11, 2026 · NIH RePORTER 1R44AI197810-01
  Organization: MUCOMMUNE, LLC; City/State: Morrisville, NC; Project number: 1R44AI197810-01; Activity code: R44; Fiscal year: 2026; Award notice date: 2026-09-11; FY total cost (award amount): 1006467; Administering IC: National Institute of Allergy and Infectious Diseases; Project title: SBIR: In vivo engineering of dual CD19/CD138 CAR-T cells for treatment of Systemic Lupus Erythematosus; Organization type: Domestic For-Profits
- Sep 7, 2026 · NIH RePORTER 1P50HD123737-01
  Organization: MUCOMMUNE, LLC; City/State: Morrisville, NC; Project number: 1P50HD123737-01; Activity code: P50; Fiscal year: 2026; Award notice date: 2026-09-07; FY total cost (award amount): 1860006; Administering IC: Eunice Kennedy Shriver National Institute of Child Health and Human Development; Project title: Preclinical and clinical development of on-demand and sustained non-hormonal contraceptives based on highly multivalent contraceptive antibody; Organization type: Domestic For-Profits
- Sep 7, 2026 · NIH RePORTER 1P50HD123737-01
  Organization: MUCOMMUNE, LLC; City/State: Morrisville, NC; Project number: 1P50HD123737-01; Activity code: P50; Fiscal year: 2026; Award notice date: 2026-09-07; FY total cost (award amount): 1441607; Administering IC: Eunice Kennedy Shriver National Institute of Child Health and Human Development; Project title: Clinical development of MM011, an instantly dissolving vaginal tablet releasing HCMA for on-demand non-hormonal contraception; Organization type: Domestic For-Profits
- Sep 7, 2026 · NIH RePORTER 1P50HD123737-01
  Organization: MUCOMMUNE, LLC; City/State: Morrisville, NC; Project number: 1P50HD123737-01; Activity code: P50; Fiscal year: 2026; Award notice date: 2026-09-07; FY total cost (award amount): 208837; Administering IC: Eunice Kennedy Shriver National Institute of Child Health and Human Development; Project title: Establishing a rhesus macaque post-coital test model to predict clinical efficacy of HCMA contraceptives; Organization type: Domestic For-Profits
- Sep 7, 2026 · NIH RePORTER 1P50HD123737-01
  Organization: MUCOMMUNE, LLC; City/State: Morrisville, NC; Project number: 1P50HD123737-01; Activity code: P50; Fiscal year: 2026; Award notice date: 2026-09-07; FY total cost (award amount): 95436; Administering IC: Eunice Kennedy Shriver National Institute of Child Health and Human Development; Project title: Biospecimen Core supporting the preclinical and clinical development of highly multivalent contraceptive antibody (HMCA); Organization type: Domestic For-Profits
- Sep 7, 2026 · NIH RePORTER 1P50HD123737-01
  Organization: MUCOMMUNE, LLC; City/State: Morrisville, NC; Project number: 1P50HD123737-01; Activity code: P50; Fiscal year: 2026; Award notice date: 2026-09-07; FY total cost (award amount): 82731; Administering IC: Eunice Kennedy Shriver National Institute of Child Health and Human Development; Project title: HMCA-CDRC: Administrative Core; Organization type: Domestic For-Profits
- Sep 7, 2026 · NIH RePORTER 1P50HD123737-01
  Organization: MUCOMMUNE, LLC; City/State: Morrisville, NC; Project number: 1P50HD123737-01; Activity code: P50; Fiscal year: 2026; Award notice date: 2026-09-07; FY total cost (award amount): 31395; Administering IC: Eunice Kennedy Shriver National Institute of Child Health and Human Development; Project title: Clinical development of MM012, a vaginal ring releasing HCMA for month-long non-hormonal contraception; Organization type: Domestic For-Profits
- Sep 4, 2026 · NIH RePORTER 5R44HD118898-02
  Organization: MUCOMMUNE, LLC; City/State: Morrisville, NC; Project number: 5R44HD118898-02; Activity code: R44; Fiscal year: 2026; Award notice date: 2026-09-04; FY total cost (award amount): 1168977; Administering IC: Eunice Kennedy Shriver National Institute of Child Health and Human Development; Project title: Fast Dissolving MM008 Tablet for Instant On-Demand Non-Hormonal Contraception; Organization type: Domestic For-Profits
- Aug 26, 2026 · NIH RePORTER 5R44CA306674-02
  Organization: MUCOMMUNE, LLC; City/State: Morrisville, NC; Project number: 5R44CA306674-02; Activity code: R44; Fiscal year: 2026; Award notice date: 2026-08-26; FY total cost (award amount): 1025819; Administering IC: National Cancer Institute; Project title: SBIR: In vivo engineering of B7-H3.CAR-T cells for ovarian cancer therapy; Organization type: Domestic For-Profits
- Aug 13, 2026 · NIH RePORTER 5R44CA310402-02
  Organization: MUCOMMUNE, LLC; City/State: Morrisville, NC; Project number: 5R44CA310402-02; Activity code: R44; Fiscal year: 2026; Award notice date: 2026-08-13; FY total cost (award amount): 1146083; Administering IC: National Cancer Institute; Project title: SBIR: In vivo engineering of multifaceted B7H3.CAR-T cells for cellular immunotherapy of pancreatic ductal adenocarcinoma; Organization type: Domestic For-Profits
- Aug 5, 2026 · NIH RePORTER 5R43AI189008-02
  Organization: MUCOMMUNE, LLC; City/State: Morrisville, NC; Project number: 5R43AI189008-02; Activity code: R43; Fiscal year: 2026; Award notice date: 2026-08-05; FY total cost (award amount): 309210; Administering IC: National Institute of Allergy and Infectious Diseases; Project title: Engineering a physiologically-tuned reservoir intravaginal ring releasing lactic acid for the treatment and prevention of bacterial vaginosis; Organization type: Domestic For-Profits
- May 26, 2026 · NIH RePORTER 5R44AI192170-02
  Organization: MUCOMMUNE, LLC; City/State: Morrisville, NC; Project number: 5R44AI192170-02; Activity code: R44; Fiscal year: 2026; Award notice date: 2026-05-26; FY total cost (award amount): 992780; Administering IC: National Institute of Allergy and Infectious Diseases; Project title: IND-enabling development of MM-009, a reservoir-intravaginal ring for ultra-highrates of month-long lactic acid release to treat and prevent bacterial vaginosis; Organization type: Domestic For-Profits
- Mar 4, 2026 · NIH RePORTER 4R33HD117428-02
  Organization: MUCOMMUNE, LLC; City/State: Morrisville, NC; Project number: 4R33HD117428-02; Activity code: R33; Fiscal year: 2026; Award notice date: 2026-03-04; FY total cost (award amount): 550000; Administering IC: Eunice Kennedy Shriver National Institute of Child Health and Human Development; Project title: Development of an ultrapotent anti-sperm antibody construct for non-hormonal contraception; Organization type: Domestic For-Profits

Job counts as of Oct 18, 2026. All funding and NIH signals

Timeline

Sep 17, 2026 Grant Government grant — SBIR: $1.16M (annual award, as published), announced Sep 17, 2026. Agency: NIH/NICHD. Source: government award database. source ↗
Sep 11, 2026 Grant Government grant — SBIR: $1.01M (annual award, as published), announced Sep 11, 2026. Agency: NIH/NIAID. Source: government award database. source ↗
Sep 7, 2026 Grant Government grant — NIH P50: $1.44M (annual award, as published), announced Sep 7, 2026. Agency: NIH/NICHD. Source: government award database. source ↗
Sep 7, 2026 Grant Government grant — NIH P50: $95,436 (annual award, as published), announced Sep 7, 2026. Agency: NIH/NICHD. Source: government award database. source ↗
Sep 7, 2026 Grant Government grant — NIH P50: $208,837 (annual award, as published), announced Sep 7, 2026. Agency: NIH/NICHD. Source: government award database. source ↗
Sep 7, 2026 Grant Government grant — NIH P50: $31,395 (annual award, as published), announced Sep 7, 2026. Agency: NIH/NICHD. Source: government award database. source ↗
Sep 7, 2026 Grant Government grant — NIH P50: $1.86M (annual award, as published), announced Sep 7, 2026. Agency: NIH/NICHD. Source: government award database. source ↗
Sep 7, 2026 Grant Government grant — NIH P50: $82,731 (annual award, as published), announced Sep 7, 2026. Agency: NIH/NICHD. Source: government award database. source ↗
Sep 4, 2026 Grant Government grant — SBIR: $1.17M (annual award, as published), announced Sep 4, 2026. Agency: NIH/NICHD. Source: government award database. source ↗
Aug 26, 2026 Grant Government grant — SBIR: $1.03M (annual award, as published), announced Aug 26, 2026. Agency: NIH/NCI. Source: government award database. source ↗
Aug 13, 2026 Grant Government grant — SBIR: $1.15M (annual award, as published), announced Aug 13, 2026. Agency: NIH/NCI. Source: government award database. source ↗
Aug 5, 2026 Grant Government grant — SBIR: $309,210 (annual award, as published), announced Aug 5, 2026. Agency: NIH/NIAID. Source: government award database. source ↗
May 26, 2026 Grant Government grant — SBIR: $992,780 (annual award, as published), announced May 26, 2026. Agency: NIH/NIAID. Source: government award database. source ↗
Mar 4, 2026 Grant Government grant — NIH R33: $550,000 (annual award, as published), announced Mar 4, 2026. Agency: NIH/NICHD. Source: government award database. source ↗
Sep 17, 2025 Grant Government grant — SBIR: $409,732 (annual award, as published), announced Sep 17, 2025. Agency: NIH/NCI. Source: government award database. source ↗
Sep 15, 2025 Grant Government grant — SBIR: $1.15M (annual award, as published), announced Sep 15, 2025. Agency: NIH/NCI. Source: government award database. source ↗
Sep 12, 2025 Grant Government grant — SBIR: $1.13M (annual award, as published), announced Sep 12, 2025. Agency: NIH/NICHD. Source: government award database. source ↗
Sep 10, 2025 Grant Government grant — SBIR: $1.03M (annual award, as published), announced Sep 10, 2025. Agency: NIH/NCI. Source: government award database. source ↗
Sep 8, 2025 Grant Government grant — SBIR: $359,608 (annual award, as published), announced Sep 8, 2025. Agency: NIH/NIDDK. Source: government award database. source ↗
Aug 21, 2025 Grant Government grant — SBIR: $310,136 (annual award, as published), announced Aug 21, 2025. Agency: NIH/NIAID. Source: government award database. source ↗
Jul 1, 2025 Grant Government grant — NIH N43: $306,183 (annual award, as published), announced Jul 1, 2025. Agency: NIH/NIAID. Source: government award database. source ↗
Jun 23, 2025 Grant Government grant — SBIR: $1.02M (annual award, as published), announced Jun 23, 2025. Agency: NIH/NIAID. Source: government award database. source ↗
Mar 24, 2025 Grant Government grant — NIH R61: $380,692 (annual award, as published), announced Mar 24, 2025. Agency: NIH/NICHD. Source: government award database. source ↗
Dec 20, 2024 Grant Government grant — SBIR: $291,458 (annual award, as published), announced Dec 20, 2024. Agency: NIH/NIAID. Source: government award database. source ↗

Funding

Last 2 years.

Sep 17, 2026 Government grant — SBIR: $1.16M (annual award, as published), announced Sep 17, 2026. Agency: NIH/NICHD. Source: government award database. source ↗
Sep 11, 2026 Government grant — SBIR: $1.01M (annual award, as published), announced Sep 11, 2026. Agency: NIH/NIAID. Source: government award database. source ↗
Sep 7, 2026 Government grant — NIH P50: $1.44M (annual award, as published), announced Sep 7, 2026. Agency: NIH/NICHD. Source: government award database. source ↗
Sep 7, 2026 Government grant — NIH P50: $95,436 (annual award, as published), announced Sep 7, 2026. Agency: NIH/NICHD. Source: government award database. source ↗
Sep 7, 2026 Government grant — NIH P50: $208,837 (annual award, as published), announced Sep 7, 2026. Agency: NIH/NICHD. Source: government award database. source ↗
Sep 7, 2026 Government grant — NIH P50: $31,395 (annual award, as published), announced Sep 7, 2026. Agency: NIH/NICHD. Source: government award database. source ↗
Sep 7, 2026 Government grant — NIH P50: $1.86M (annual award, as published), announced Sep 7, 2026. Agency: NIH/NICHD. Source: government award database. source ↗
Sep 7, 2026 Government grant — NIH P50: $82,731 (annual award, as published), announced Sep 7, 2026. Agency: NIH/NICHD. Source: government award database. source ↗
Sep 4, 2026 Government grant — SBIR: $1.17M (annual award, as published), announced Sep 4, 2026. Agency: NIH/NICHD. Source: government award database. source ↗
Aug 26, 2026 Government grant — SBIR: $1.03M (annual award, as published), announced Aug 26, 2026. Agency: NIH/NCI. Source: government award database. source ↗
Aug 13, 2026 Government grant — SBIR: $1.15M (annual award, as published), announced Aug 13, 2026. Agency: NIH/NCI. Source: government award database. source ↗
Aug 5, 2026 Government grant — SBIR: $309,210 (annual award, as published), announced Aug 5, 2026. Agency: NIH/NIAID. Source: government award database. source ↗
May 26, 2026 Government grant — SBIR: $992,780 (annual award, as published), announced May 26, 2026. Agency: NIH/NIAID. Source: government award database. source ↗
Mar 4, 2026 Government grant — NIH R33: $550,000 (annual award, as published), announced Mar 4, 2026. Agency: NIH/NICHD. Source: government award database. source ↗
Sep 17, 2025 Government grant — SBIR: $409,732 (annual award, as published), announced Sep 17, 2025. Agency: NIH/NCI. Source: government award database. source ↗
Sep 15, 2025 Government grant — SBIR: $1.15M (annual award, as published), announced Sep 15, 2025. Agency: NIH/NCI. Source: government award database. source ↗
Sep 12, 2025 Government grant — SBIR: $1.13M (annual award, as published), announced Sep 12, 2025. Agency: NIH/NICHD. Source: government award database. source ↗
Sep 10, 2025 Government grant — SBIR: $1.03M (annual award, as published), announced Sep 10, 2025. Agency: NIH/NCI. Source: government award database. source ↗
Sep 8, 2025 Government grant — SBIR: $359,608 (annual award, as published), announced Sep 8, 2025. Agency: NIH/NIDDK. Source: government award database. source ↗
Aug 21, 2025 Government grant — SBIR: $310,136 (annual award, as published), announced Aug 21, 2025. Agency: NIH/NIAID. Source: government award database. source ↗
Jul 1, 2025 Government grant — NIH N43: $306,183 (annual award, as published), announced Jul 1, 2025. Agency: NIH/NIAID. Source: government award database. source ↗
Jun 23, 2025 Government grant — SBIR: $1.02M (annual award, as published), announced Jun 23, 2025. Agency: NIH/NIAID. Source: government award database. source ↗
Mar 24, 2025 Government grant — NIH R61: $380,692 (annual award, as published), announced Mar 24, 2025. Agency: NIH/NICHD. Source: government award database. source ↗
Dec 20, 2024 Government grant — SBIR: $291,458 (annual award, as published), announced Dec 20, 2024. Agency: NIH/NIAID. Source: government award database. source ↗

NIH awards 35

Annual award amounts. Total $17.8M.

Feb 14, 2024 NIH award 5R44AI157661-03 FY2024: $1,037,049 awarded for that fiscal year; activity R44 (SBIR); PI CONE, RICHARD; recipient as written: MUCOMMUNE, LLC, Morrisville, NC. SBIR: In vivo validation and IND-enabling devel source ↗
Jan 22, 2024 NIH award 1R43AI181354-01 FY2024: $291,458 awarded for that fiscal year; activity R43 (SBIR); PI KUSHIRO, KEIICHIRO; recipient as written: MUCOMMUNE, LLC, Morrisville, NC. IND-enabling development of MM010, a PEG-spe source ↗
Aug 31, 2023 NIH award 5R33HD099747-05 FY2023: $535,972 awarded for that fiscal year; activity R33 (OTHER_NIH); PI MOENCH, THOMAS RAY; recipient as written: MUCOMMUNE, LLC, Morrisville, NC. Nonhormonal contraceptive intravaginal source ↗
Aug 22, 2023 NIH award 5R44HD107824-02 FY2023: $1,028,445 awarded for that fiscal year; activity R44 (SBIR); PI CONE, RICHARD; recipient as written: MUCOMMUNE, LLC, Morrisville, NC. IND‐enabling development of MM‐008 IVR, an anti source ↗
Mar 30, 2023 NIH award 1R43AI177160-01 FY2023: $306,483 awarded for that fiscal year; activity R43 (SBIR); PI KUSHIRO, KEIICHIRO; recipient as written: MUCOMMUNE, LLC, Morrisville, NC. Highly Acidifying Intravaginal Rings with La source ↗
Mar 16, 2023 NIH award 4R44AI157661-02 FY2023: $1,036,484 awarded for that fiscal year; activity R44 (SBIR); PI CONE, RICHARD; recipient as written: MUCOMMUNE, LLC, Morrisville, NC. SBIR: In vivo validation and IND-enabling devel source ↗
Sep 19, 2022 NIH award 1R44HD107824-01 FY2022: $1,039,122 awarded for that fiscal year; activity R44 (SBIR); PI CONE, RICHARD; recipient as written: MUCOMMUNE, LLC, Morrisville, NC. IND‐enabling development of MM‐008 IVR, an anti source ↗
Sep 1, 2022 NIH award 1R43HD108823-01 FY2022: $259,499 awarded for that fiscal year; activity R43 (SBIR); PI KUSHIRO, KEIICHIRO; recipient as written: MUCOMMUNE, LLC, Morrisville, NC. User-based identification of preferred desig source ↗
Aug 30, 2022 NIH award 5R33HD099747-04 FY2022: $540,726 awarded for that fiscal year; activity R33 (OTHER_NIH); PI MOENCH, THOMAS RAY; recipient as written: MUCOMMUNE, LLC, Morrisville, NC. Nonhormonal contraceptive intravaginal source ↗
Aug 29, 2022 NIH award 1R43AI172654-01 FY2022: $306,500 awarded for that fiscal year; activity R43 (SBIR); PI KUSHIRO, KEIICHIRO; recipient as written: MUCOMMUNE, LLC, Morrisville, NC. Fast dissolving antibody tablets for prevent source ↗
Jun 30, 2022 NIH award 1R43HD108822-01 FY2022: $277,713 awarded for that fiscal year; activity R43 (SBIR); PI KUSHIRO, KEIICHIRO; recipient as written: MUCOMMUNE, LLC, Morrisville, NC. Development of a qualified pharmacokinetic b source ↗
May 3, 2022 NIH award 5R44AI141054-03 FY2022: $891,585 awarded for that fiscal year; activity R44 (SBIR); PI CONE, RICHARD; recipient as written: MUCOMMUNE, LLC, Morrisville, NC. Development of RespiraClear for targeted mucosal source ↗
Apr 8, 2022 NIH award 5R44HD097063-03 FY2022: $791,080 awarded for that fiscal year; activity R44 (SBIR); PI KUSHIRO, KEIICHIRO; recipient as written: MUCOMMUNE, LLC, Morrisville, NC. Capsule-intravaginal ring for sustained rele source ↗
Sep 7, 2021 NIH award 5R44HD100231-02 FY2021: $756,985 awarded for that fiscal year; activity R44 (SBIR); PI CONE, RICHARD; recipient as written: MUCOMMUNE, LLC, Morrisville, NC. In vivo dose finding for an antibody based nonhor source ↗
Aug 24, 2021 NIH award 4R33HD099747-03 FY2021: $545,344 awarded for that fiscal year; activity R33 (OTHER_NIH); PI MOENCH, THOMAS RAY; recipient as written: MUCOMMUNE, LLC, Morrisville, NC. Nonhormonal contraceptive intravaginal source ↗
Jul 30, 2021 NIH award 1R43HD105277-01 FY2021: $265,970 awarded for that fiscal year; activity R43 (SBIR); PI CONE, RICHARD; recipient as written: MUCOMMUNE, LLC, Morrisville, NC. Multipurpose vaginal ring for non-hormonal contra source ↗
May 7, 2021 NIH award 4R44AI141054-02 FY2021: $658,372 awarded for that fiscal year; activity R44 (SBIR); PI CONE, RICHARD; recipient as written: MUCOMMUNE, LLC, Morrisville, NC. Development of RespiraClear for targeted mucosal source ↗
Apr 1, 2021 NIH award 4R44HD097063-02 FY2021: $910,955 awarded for that fiscal year; activity R44 (SBIR); PI KUSHIRO, KEIICHIRO; recipient as written: MUCOMMUNE, LLC, Morrisville, NC. Capsule-intravaginal ring for sustained rele source ↗
Mar 4, 2021 NIH award 1R44AI157661-01 FY2021: $306,500 awarded for that fiscal year; activity R44 (SBIR); PI CONE, RICHARD; recipient as written: MUCOMMUNE, LLC, Morrisville, NC. SBIR: In vivo validation and IND-enabling develop source ↗
Feb 24, 2021 NIH award 1R43AI157652-01 FY2021: $306,500 awarded for that fiscal year; activity R43 (SBIR); PI CONE, RICHARD; recipient as written: MUCOMMUNE, LLC, Morrisville, NC. Vaginal ring for sustained release of lactic acid source ↗
Nov 27, 2020 NIH award 5R44AI138728-03 FY2021: $995,652 awarded for that fiscal year; activity R44 (SBIR); PI CONE, RICHARD; recipient as written: MUCOMMUNE, LLC, Morrisville, NC. In vivo dose finding for IN-002 in neonatal lambs source ↗
Sep 15, 2020 NIH award 1R44HD100231-01A1 FY2020: $972,804 awarded for that fiscal year; activity R44 (SBIR); PI CONE, RICHARD; recipient as written: MUCOMMUNE, LLC, Morrisville, NC. In vivo dose finding for an antibody based nonh source ↗
Sep 10, 2020 NIH award 5R61HD099747-02 FY2020: $310,245 awarded for that fiscal year; activity R61 (OTHER_NIH); PI MOENCH, THOMAS RAY; recipient as written: MUCOMMUNE, LLC, Morrisville, NC. Nonhormonal contraceptive intravaginal source ↗
Jun 23, 2020 NIH award 1R43AI155185-01 FY2020: $275,437 awarded for that fiscal year; activity R43 (SBIR); PI CONE, RICHARD; recipient as written: MUCOMMUNE, LLC, Morrisville, NC. Inhaled 'muco-trapping' antibody as universal imm source ↗
Jun 22, 2020 NIH award 1R43AI149894-01A1 FY2020: $261,742 awarded for that fiscal year; activity R43 (SBIR); PI CONE, RICHARD; recipient as written: MUCOMMUNE, LLC, Morrisville, NC. Aerosol immunotherapy for treatment of human me source ↗
Dec 23, 2019 NIH award 2R44AI138728-02 FY2020: $999,032 awarded for that fiscal year; activity R44 (SBIR); PI CONE, RICHARD; recipient as written: MUCOMMUNE, LLC, Morrisville, NC. In vivo dose finding for IN-002 in neonatal lambs source ↗
Sep 14, 2019 NIH award 1R61HD099747-01 FY2019: $295,767 awarded for that fiscal year; activity R61 (OTHER_NIH); PI MOENCH, THOMAS RAY; recipient as written: MUCOMMUNE, LLC, Morrisville, NC. Nonhormonal contraceptive intravaginal source ↗
Aug 19, 2019 NIH award 1R44AI141054-01A1 FY2019: $224,961 awarded for that fiscal year; activity R44 (SBIR); PI CONE, RICHARD; recipient as written: MUCOMMUNE, LLC, Morrisville, NC. Development of RespiraClear for targeted mucosa source ↗
Jan 26, 2019 NIH award 1R43HD097941-01 FY2019: $224,728 awarded for that fiscal year; activity R43 (SBIR); PI CONE, RICHARD; recipient as written: MUCOMMUNE, LLC, Morrisville, NC. Non-hormonal contraception based on vaginal deliv source ↗
Sep 17, 2018 NIH award 1R44HD097063-01 FY2018: $224,934 awarded for that fiscal year; activity R44 (SBIR); PI CONE, RICHARD; recipient as written: MUCOMMUNE, LLC, Morrisville, NC. Capsule-intravaginal ring for sustained release o source ↗